Result
€151,249 ▲ 345%
The result rose in 2025 from €33,995 to €151,249.
MDV ENDO
Lifetime
3 annual accounts with figures on one time axispeak €201,539 (2025)
€201,539▲ 337%
lowest -€462 (2023)
€151,249▲ 345%
peak €189,782 (2025)
€189,782▲ 393%
€64,030▲ 318%
Board1 name since 2023
1 director
Documentsfilings and deeds
12-02-2026169 days before the deadline
2025micro format
Gross margin from €46,162 to €201,539Result from €33,995 to €151,249Equity from €38,534 to €189,782Debts from €15,300 to €64,030Investments €62,172Cash from €33,742 to €181,063
1 name is hidden.
Create a free account or sign in to see the name.
Key points
from the 2025 annual accountsTurnover
≈ €370,000 estimated
The micro format states no turnover.
Investments
€62,582 27.5 × depreciation
Green is investment, beige is depreciation.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as MDV ENDO has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for MDV ENDO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The Checked score is hidden.
Create a free account or sign in to see the score and the bankruptcy probability.
Signals
5 signals are hidden.
Create a free account or sign in to see the signals.
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0804623710
Incorporation
Founding capital of €5,000, 100 shares · Founder: · Appointment: (director) · published on 09-08-2023 · Gazette deed
First establishment
Richard Neyberghlaan 26, Brussels
1 name is hidden.
Create a free account or sign in to see the name.
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MDV ENDO Brussels | €253,812 | €201,539 | 74.8% | - |
| Kapila – Ostrovska Clinic Brussels | €253,860 | €185,044 | 76.2% | - |
| AZGAS MEDICAL Woluwe-Saint-Lambert | €242,733 | €196,430 | 73.6% | - |
| Dr. Tijs Bringmans, cardioloog Sint-Katelijne-Waver | €263,267 | €190,711 | 71.6% | - |
| KMDerma Maaseik | €250,940 | €188,638 | 94.2% | - |
| FG NEUROCHIRURGIE Aubel | €274,897 | €204,889 | 87.3% | - |
| Dr. Sara De Burghgraeve Bruges | €273,243 | €213,454 | 79.8% | - |
These companies have the same main activity as MDV ENDO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €243,000 and €275,000, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 07-08-2023Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.348.080.9781020 Brussels, since 07-08-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 04-07-2025
Annual accounts 2025
- €253,812▲ 371%
- Filing
- Filed on 12-02-2026, 169 days before the end of the filing period
Insights on MDV ENDO
MDV ENDO files the micro format. That format states no turnover. The gross margin rose from €663 in 2023 to €201,539 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MDV ENDO
- What is the company number of MDV ENDO?
- The company number of MDV ENDO is 0804.623.710. The VAT number is the same number with BE in front: BE 0804.623.710.
- Where is MDV ENDO based?
- The registered office is at Richard Neyberghlaan 26, 1020 Brussels.Company details
- What does MDV ENDO do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of MDV ENDO?
- MDV ENDO is a private limited company (BV).
- When was MDV ENDO founded?
- MDV ENDO was founded on 07-08-2023.
- Is MDV ENDO still active?
- Yes, MDV ENDO is an active enterprise in the KBO register.
- What is the turnover of MDV ENDO?
- The turnover in financial year 2025 is ≈ €370,000. This figure is estimated from the gross margin of €201,539 and 41 comparable companies (NACE 86220). It probably lies between €320,000 and €500,000.Financials
- Is MDV ENDO profitable?
- In financial year 2025, MDV ENDO made a profit of €151,249.
- Where can I find the annual accounts of MDV ENDO?
- MDV ENDO filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MDV ENDO due?
- MDV ENDO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.